Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3

Author:

Liu Bin1,Lu Yi2,Li Jinzhi3,Liu Yanping4,Liu Jian2,Wang Weiguo5

Affiliation:

1. Department of Orthopedics; Liaocheng Second People's Hospital; Linqing City Shandong Province China

2. Department of Orthopedics; The People's Hospital of Zhangqiu City; Zhangqiu City Shandong Province China

3. Department of Pathology; The People's Hospital of Zhangqiu City; Zhangqiu City Shandong Province China

4. Department of Pediatric Gastrointestinal Surgery; The People's Hospital of Zhangqiu City; Zhangqiu City Shandong Province China

5. Department of Interventional Radiology; Affiliated Hospital of Jiangnan University and Wuxi 4th People's Hospital; Wuxi City Jiangsu Province China

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Reference33 articles.

1. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program;Mirabello;Cancer,2009

2. Osteosarcoma;Ritter;Ann Oncol,2010

3. Epidemiological data for common bone sarcomas;Qureshi;Asian Pac J Cancer Prev,2010

4. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up;Bielack;Ann Oncol,2009

5. Strategies for the targeted delivery of therapeutics for osteosarcoma;Hughes;Expert Opin Drug Deliv,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3